Free Trial

LENSAR (LNSR) News Today

LENSAR logo
$7.57 -0.32 (-4.06%)
(As of 05:27 PM ET)
LENSAR, Inc. stock logo
LENSAR (NASDAQ:LNSR) Trading Up 0.9% - Time to Buy?
LENSAR (NASDAQ:LNSR) Stock Price Up 0.9% - Should You Buy?
LENSAR, Inc. stock logo
LENSAR, Inc. (NASDAQ:LNSR) Sees Significant Drop in Short Interest
LENSAR, Inc. (NASDAQ:LNSR - Get Free Report) saw a significant decrease in short interest in October. As of October 31st, there was short interest totalling 49,800 shares, a decrease of 22.6% from the October 15th total of 64,300 shares. Based on an average daily volume of 31,200 shares, the short-interest ratio is currently 1.6 days. Approximately 0.6% of the company's stock are short sold.
LENSAR Inc. Reports Strong Q3 2024 Growth
LENSAR, Inc. (LNSR) Q3 2024 Earnings Call Transcript
Lake Street Sticks to Its Buy Rating for LENSAR (LNSR)
LENSAR, Inc. stock logo
LENSAR (LNSR) Scheduled to Post Earnings on Thursday
LENSAR (NASDAQ:LNSR) will be releasing earnings before the market opens on Thursday, November 7, Zacks reports.
LENSAR, Inc. stock logo
LENSAR, Inc. (NASDAQ:LNSR) Short Interest Down 16.6% in August
LENSAR, Inc. (NASDAQ:LNSR - Get Free Report) saw a significant decrease in short interest during the month of August. As of August 15th, there was short interest totalling 59,600 shares, a decrease of 16.6% from the July 31st total of 71,500 shares. Based on an average daily volume of 24,000 shares, the days-to-cover ratio is presently 2.5 days. Approximately 0.7% of the shares of the company are short sold.
LENSAR (LNSR) Gets a Buy from Lake Street
LENSAR, Inc. (LNSR) Q2 2024 Earnings Call Transcript
LNSR Stock Earnings: LENSAR Misses EPS, Beats Revenue for Q2 2024
What Wall Street expects from LENSAR's earnings
Lake Street Keeps Their Buy Rating on LENSAR (LNSR)
LENSAR, Inc. stock logo
LENSAR (LNSR) Scheduled to Post Quarterly Earnings on Thursday
LENSAR (NASDAQ:LNSR) will be releasing earnings before the market opens on Thursday, August 8, Zacks reports.
LENSAR, Inc. stock logo
LENSAR (NASDAQ:LNSR) Stock Price Up 5.8%
LENSAR (NASDAQ:LNSR) Trading 5.8% Higher
LENSAR Inc Ordinary Shares LNSR
Analysts’ Top Healthcare Picks: 89bio (ETNB), UnitedHealth (UNH)
LENSAR, Inc. stock logo
LENSAR (NASDAQ:LNSR) Posts Earnings Results
LENSAR (NASDAQ:LNSR - Get Free Report) issued its earnings results on Monday. The company reported ($0.22) earnings per share for the quarter, hitting the consensus estimate of ($0.22). LENSAR had a negative return on equity of 34.41% and a negative net margin of 32.13%.
LENSAR Q4 2023 Earnings Preview
Navigating 6 Analyst Ratings For Viridian Therapeutics
Get LENSAR News Delivered to You Automatically

Sign up to receive the latest news and ratings for LNSR and its competitors with MarketBeat's FREE daily newsletter.

Do this Before Elon’s Reveal on January 22nd (Ad)

Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.

I urge you to watch this video now.

LNSR Media Mentions By Week

LNSR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LNSR
News Sentiment

-0.50

0.54

Average
Medical
News Sentiment

LNSR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LNSR Articles
This Week

1

1

LNSR Articles
Average Week

Get LENSAR News Delivered to You Automatically

Sign up to receive the latest news and ratings for LNSR and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:LNSR) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners